Iridex (IRIX) Free Cash Flow Growth (3y) (2014 - 2026)
Iridex (IRIX) Free Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -27.72% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -20.37% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 77.20% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.32% |
| 10 | Iridex | 19.39 Mn | 14.79 Mn | 4.74 Mn | 20.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 20.76% |
| Jan 3, 2026 | 31.78% |
| Sep 27, 2025 | 18.50% |
| Jun 28, 2025 | 46.58% |
| Mar 29, 2025 | 29.28% |
| Dec 28, 2024 | -28.30% |
| Mar 30, 2024 | -28.87% |
| Sep 30, 2023 | -87.93% |
| Jul 1, 2023 | 16.63% |
| Apr 1, 2023 | -23.80% |
| Dec 31, 2022 | -105.78% |
| Oct 1, 2022 | 5.67% |
| Jul 2, 2022 | -24.08% |
| Apr 2, 2022 | 5.33% |
| Jan 1, 2022 | 93.95% |
| Apr 3, 2021 | 80.88% |
| Sep 26, 2020 | 30.10% |
| Jun 27, 2020 | -65.91% |
| Mar 28, 2020 | 8.15% |
| Dec 28, 2019 | 31.94% |